Trial intelligence / Profile preview

Prophylactic fibrinogen vs tranexamic acid in radical cystectomy

IRCT20230204057318N4Phase 3Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Nov 2023
Modality
Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3 trial of Fibrinogen human and tranexamic acid in perioperative hemorrhage (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Started Nov 2023; status: completed.

02

Drugs

Fibrinogen humantranexamic acid
03

Conditions

perioperative hemorrhage

Beyond the preview

Go deeper on IRCT20230204057318N4.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20230204057318N4.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call